Clinical Trial: Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets

U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07710326) titled 'Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV261 Tablets' on July 13.

Brief Summary: This is a randomized, double-blind, placebo-controlled, multiple ascending-dose study to evaluate the safety, tolerability and pharmacokinetics characteristics of VV261 tablets in healthy adults.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: VV261 600mg TID group

6 participants receive VV261 100mg 6 tablets,three times daily,orally; 2 participants will receive placebo,orally

DRUG: VV261 900mg TID group

6 participants receive VV261 100mg 9 tablets,three times dail...